Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Feb 20, 2025

SELL
$119.79 - $167.35 $2.04 Million - $2.84 Million
-16,989 Closed
0 $0
Q2 2024

Feb 20, 2025

SELL
$120.0 - $182.95 $127,800 - $194,841
-1,065 Reduced 5.9%
16,989 $2.14 Million
Q1 2024

Feb 20, 2025

BUY
$170.78 - $208.42 $3.08 Million - $3.76 Million
18,054 New
18,054 $3.32 Million

Others Institutions Holding RGEN

About REPLIGEN CORP


  • Ticker RGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 55,491,200
  • Market Cap $9.03B
  • Description
  • Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....
More about RGEN
Track This Portfolio

Track Resona Asset Management Co.,Ltd. Portfolio

Follow Resona Asset Management Co.,Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Resona Asset Management Co.,Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Resona Asset Management Co.,Ltd. with notifications on news.